Leading the World with Minimally Invasive Solutions
This quarter was marked by dynamic global engagement, with increased participation in key conferences, hands-on training sessions, and deeper collaboration with our distributors. Expanding across various applications, we continue to strengthen our presence and drive innovation in the field of minimally invasive solutions.
Dubai, UAE Feb 20-22
We successfully showcased our advanced ablation solutions at Endo Dubai 2025, engaging with over 50 physicians from diverse regions, including the UAE, Europe, and Asia. With strong support from our local distributor, AL Rowais, our booth attracted significant interest in RFA, particularly in their applications for gynecology. Key discussions centered on
Anaheim, USA Feb 04-06
We recently participated in MD&M West 2025, highlighting our diverse product portfolio and advanced development capabilities. This exhibition provided a valuable platform to showcase our expertise and explore opportunities in contract manufacturing. Engaging with industry leaders and potential partners, we reinforced our commitment to delivering innovative solutions and expanding global collaboration.
Beijing, China Mar 21-23
Although the Chinese market is highly competitive with many local brands, we participated in this congress as the only foreign brand in the RFA field. We showcased the performance and quality of our products—proven over many years in the global market—as well as our strong global references. Also our booth featured RF tumor ablation demos on soft tissue models, engaging key specialists and showcasing our precision and cooling technology. The discussions reinforced interest in minimally invasive cancer treatment and future opportunities.
Munchen, Germany Mar 11-12
Attendance at SDK 2025 was lower than last year, and interest in thyroid RFA remains gradual as surgery continues to be the preferred approach in Germany. However, there are signs of progress, with plans to introduce a thyroid ablation workshop at next year’s congress. Through discussions at the event, we gained valuable insights into the key challenges a ecting adoption. This understanding will help shape our long-term strategy, allowing us to refine our approach and identify the most e ective ways to expand awareness and acceptance in the market.
China Mar 28-29
At the recent Shandong Thyroid Surgery Conference in Jinan, we exhibited alongside key industry players, engaging with over 100 specialists from Shandong and neighboring provinces. Our booth featured M-3004C and electrodes, complemented by a live bovine tissue demonstration, drawing strong interest from attending surgeons. The conference largely focused on thyroid surgery, with discussions highlighting ongoing debates around PTMC ablation in China. While surgical approaches remain the standard, there is increasing dialogue on the role of thermal ablation in specific cases. Our presence reinforced the growing recognition of RFA as a viable treatment option, paving the way for further engagement in this evolving market.
Nashville, USA Feb 20-22
At SIR 2025, we continued to highlight advancements in RF ablation, presenting our tumor and thyroid ablation solutions alongside Mi-BLATOR™ microwave ablation system, which is currently undergoing FDA clearance. Our U.S. distributor, RGS Healthcare, participated in the event, providing support throughout the congress. Additionally, a hands-on station allowed attendees to experience RF ablation for thyroid and tumor treatments using our devices. As a regular participant in this annual congress, we remain committed to expanding our presence and engaging with the medical community in the U.S. market.
SIO 2025
Las Vegas, USA
Jan 30- Feb 03
At SIO 2025 in Las Vegas, we partnered with our US distributor, RGS Healthcare, to highlight our RFA solutions, with a focus on MYGEN™ and THYBLATE™ thyroid RFA. Our team supported the event with equipment and expertise. In addition to our established products, we also introduced Mi-BLATOR™ as a preview ahead of its expected FDA 510(k) clearance later this year. This provided an opportunity to generate early interest and
Mar 27-28
We recently participated in BSIC 2025 in Bristol, a highly focused spine intervention congress. Although the event was small, it attracted key specialists from the UK, Romania, Malta, and Pakistan, generating valuable leads. Over two days, we showcased our OsteoBlate™ technology, with a strong response from delegates following its demonstration in the cadaveric workshop. Our joint participation with Onco V reinforced our commitment to advancing minimally invasive spinal metastasis treatments.
Our Colombian distributor, Medinistros, proudly participated in the 4th Annual Meeting of the Scientific Group of Interventional Radiology and the 14th Annual Meeting of the Colombian Group of Neurointerventionism, held in Rionegro, Antioquia. This marks Medinistros’ first o cial promotion of the THYBLATE™ system since its successful product registration in Colombia. The event provided an excellent platform to introduce THYBLATE™’s innovative technology to leading specialists in interventional radiology and neurointervention. We are excited about the growing interest in THYBLATE™ across Latin America and look forward to continued collaboration with Medinistros to expand its presence in the region.
From January 31 to February 1, our U.S. distributor participated in the NASIT 2025 Annual Meeting, engaging with 100 leading Thyroid RFA specialists. During the hands-on workshops, they showcased our latest innovations - the ultra-precise 3mm active tip for PTMC treatment and the saline-dispersion electrode designed for e ective ablation of large nodules. The event was a valuable opportunity to connect with top clinicians and highlight our advanced solutions in the evolving field of Thyroid RFA.
Thyroid RFA Training
Feb 25-26, Budapest Hungary
We recently hosted a specialized Thyroid RFA training course with Premier Med Healthcare, bringing together 10 Saudi physicians eager to expand their expertise in minimally invasive treatments. Led by Dr. Pál Ákos Deák, a renowned interventional radiologist, the program combined theoretical lectures, hands-on practice with phantom models, and live case demonstrations. Participants gained valuable insights into the indications, techniques, and outcomes of thyroid RFA, reinforcing its growing role in modern medical practice. The enthusiasm and engagement throughout the training highlight the increasing global adoption of this innovative procedure.
Feb 24-26 Doha, Qatar
Our recent Masterclass at West Bay Hospital marked Qatar’s first-ever thyroid and gynecological radiofrequency ablation (RFA) procedures. Led by Dr. P. Bat-Ireedui, with active participation from Dr. Husam, Dr. Ertan, Dr. Amr, and international experts, the event showcased the e ectiveness of RFA through multiple successful cases. The positive reception highlighted its ease of use, precision, and potential for broader adoption. This milestone reinforces Qatar’s commitment to advancing minimally invasive medical innovations.
The 2nd Indonesian
HEMO-BLATE™ Academy
March 1-2, Jakarta, Indonesia
Following the success of the first training course in November, PT Natural Hilife hosted the 2nd HEMO-BLATE™ Academy in Jakarta, further advancing expertise in hemorrhoid radiofrequency ablation (RFA). The two-day program provided participants with in-depth theoretical education, hands-on training, and live case observations. Held at Onni Garden House and RSUD Tebet Jakarta, the course helped attendees refine their procedural skills and enhance clinical outcomes using the HEMO-BLATE™ system. With growing interest in minimally invasive treatments, this training marks another step toward expanding RFA adoption in Indonesia.
Hemorrhoids Radiofrequency Ablation Training Sessions
January 20, Chile
January 20-21, Concepción, Chile
RF MEDICAL continues to expand its reach in Latin America!
On January 20-21, a Thyroid Nodule RF Ablation Workshop was held at Hospital Guillermo Grant Benavente in Chile, led by Dr. Alexis Urra and Dr. Joaquín Ulloa, with support from guest professors Dr. Saúl Siso and Dr. Pilar Schneeberger. The event featured expert insights from Dr. Monserrath Acosta, hands-on training with simulators, and in-depth discussions on the MYGEN™ system and THYBLATE™ RF electrodes. A key step in advancing RF ablation in Chile!
Successful Webinar with Chilean Head & Neck Surgeons!
We recently co-hosted a webinar with our Chilean partner, Thiemed, for head & neck surgeons in Chile, focusing on advanced thyroid treatments. During the session, we introduced our company and THYBLATE™ thyroid RFA system, while esteemed KOL Dra. Acosta delivered a scientific presentation. The event was well-received, marking another step in our e orts to engage with the global medical community.
March 25, Santiago, Chile
RF MEDICAL Continues Advancing RF Ablation in Chile!
Following the successful January workshop, another Thyroid Nodule RF Ablation Hands-on Workshop was held on March 25 at Hospital Barros Luco Trudau, organized by our local distributor, Thiemed. RF Medical’s sales representative and product manager joined the event online at the beginning to introduce our company and THYBLATE™ RFA system, after which local physicians led the hands-on training session. This marks another important step in expanding RF ablation expertise in Chile!
We are expanding our reach with new multilingual resources and region-specific materials, ensuring better accessibility and targeted communication as we continue to grow in key markets.
Explore the Spanish version of THYBLATE™ & MYOBLATE™ websites!
Tailored Product Brochures Region-Specific Versions & Generator Compatibility
THYBLATE™ Brochures Available in:
▪ International Version
▪ EU-Compliant Version
▪ US Version (with Registered Trademark)
HEMO-BLATE™ Brochures Customized for:
As we move into the second quarter, we are gearing up for new opportunities and continued growth. Stay tuned for upcoming events, product developments, and market expansions in the months ahead!
Liver Update 2025
April 25-27 2025 Jakarta, Indonesia
MASTERCLASS
WEBINAR
PAIRS 2025
April 9-12 2025 Dubai, UAE
KSUM 2025
May 8-9 2025 Seoul, Korea
KCOG 2025
April 13 2025 Seoul, Korea
KSUS hands-on support
May 11 2025 Seoul, Korea
GYN, THYROID MASTERCLASS with D r. P. Bat-Ireedui
April 21-23 l Panama
Transforming Uterine Fibroid Management: The Role of Radiofrequency Ablation
Presented by LiNA Medical, our trusted partner
April 3 l 18:00-19:15 BST (UK) / 19:00-20:15 CET
RF Medical Co., Ltd.
#502~#507, #511, #601, World Merdian 254 Beotkkot-ro, Geumcheon-gu,
Tel. +(82) 2-2108-4200 overseas@rfa.co.kr www.rfa.co.kr